St. Louis Clinical Trials recapitalized by DFW Capital Partners

Apr. 2014

Client: SLCT is a leading clinical pharmacology and research services company focusing on psychiatric indications

Role: Edgemont Partners acted as exclusive financial advisor to St. Louis Clinical Trials in its recapitalization and merger to form Evolution Research Group sponsored by DFW Capital

Location: St. Louis, MO

Sector: Pharmaceutical Services

Lead Banker: David Blume